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Abstract
Background: In mammals, there is evidence suggesting that methyl-CpG binding proteins may
play a significant role in histone modification through their association with modification complexes
that can deacetylate and/or methylate nucleosomes in the proximity of methylated DNA. We
examined this idea for the X chromosome by studying histone modifications on the X chromosome
in normal cells and in cells from patients with ICF syndrome (Immune deficiency, Centromeric
region instability, and Facial anomalies syndrome). In normal cells the inactive X has characteristic
silencing type histone modification patterns and the CpG islands of genes subject to X inactivation
are hypermethylated. In ICF cells, however, genes subject to X inactivation are hypomethylated on
the inactive X due to mutations in the DNA methyltransferase (DNMT3B) genes. Therefore, if
DNA methylation is upstream of histone modification, the histones on the inactive X in ICF cells
should not be modified to a silent form. In addition, we determined whether a specific methyl-CpG
binding protein, MeCP2, is necessary for the inactive X histone modification pattern by studying
Rett syndrome cells which are deficient in MeCP2 function.
Results: We show here that the inactive X in ICF cells, which appears to be hypomethylated at all
CpG islands, exhibits normal histone modification patterns. In addition, in Rett cells with no
functional MeCP2 methyl-CpG binding protein, the inactive X also exhibits normal histone
modification patterns.
Conclusions: These data suggest that DNA methylation and the associated methyl-DNA binding
proteins may not play a critical role in determining histone modification patterns on the mammalian
inactive X chromosome at the sites analyzed.
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Background
Although it has been known for some time that histone
modifications play a role in gene expression [1], it is only
in the last several years that the details of these modifica-
tions have been more fully described. Acetylation and
methylation of histone tails, for example, exhibit charac-
teristic patterns for expressed and repressed genes in all
eukaryotes studied [2]. This generality of histone modifi-
cation and gene expression holds for eukaryotes with and
without DNA methylation, indicating that DNA methyla-
tion is not required for histone modification. In organ-
isms with DNA methylation, however, interactions
between histone modification and DNA methylation do
appear to exist.
In Neurospora, histone methylation appears to determine
DNA methylation patterns [3,4]. In Arabidopsis, non-CpG
DNA methylation also appears to be determined by his-
tone methyltransferases, whereas CpG methylation does
not [5,6]. In mammals, there is considerable evidence sug-
gesting that methyl-CpG binding proteins may play a sig-
nificant role in histone modification through their
association with histone deacetylases [7-11]. Mutations in
the MeCP2 methyl-DNA binding protein, which are the
cause of most Rett syndrome cases [12], support this
model, because human male and female cells with
MECP2 mutations exhibit histone hyperacetylation [10].
Histone hyperacetylation was also observed in mice with
Mecp2  mutations [13]. Thus, DNA methylation is
upstream of histone modification in this model of
methyl-DNA binding proteins and histone modification.
Another possibility is that DNA methyltransferases them-
selves may target histone deacetylases through a noncata-
lytic domain, leading to histone modifications that are
independent of other methyl-DNA binding proteins [14].
We are especially interested in the X chromosome with
respect to the question of the relationship between DNA
methylation and histone modification. The mammalian X
chromosome is unusual in that about a thousand gene-
associated CpG islands are hypermethylated on the inac-
tive X and hypomethylated on the active X. Except for
imprinted loci, methylation patterns at most other regions
of the genome are similar between homologs. Histone
modification differences known to be associated with
either silent or expressed chromatin also distinguish the
active and inactive X chromosomes [15-19]. Thus, the
mammalian X chromosome inactivation system would
appear ideal for testing whether or not a methyl DNA
binding protein – histone modification pathway exists for
the inactive X chromosome.
To examine more fully the possible relationships between
DNA methylation and histone modification, we have uti-
lized cell cultures from individuals with a human
hypomethylation disease called the ICF syndrome. This
disease is clinically characterized by "Immune deficiency,
Centromeric region instability, and Facial anomalies". In
most cases, the molecular defects result from mutations in
the DNMT3B methyltransferase gene [20-22]. Certain het-
erochromatic regions are markedly hypomethylated as a
result of these mutations, including the CpG islands on
the inactive X chromosome that are associated with genes
[23] and LINE-1 elements [24]. If DNA methylation is
upstream of histone modification, the histones on the
inactive X should not be modified to a silent form in ICF
cells. Our results indicate, however, that these histones do
have modifications typical of silenced genes, suggesting
that methyl-DNA binding proteins may not be critical
with respect to histone modification on the inactive X
chromosome. In addition, we examined clonal primary
fibroblast cultures from two individuals with Rett syn-
drome and found that the histone modification pattern of
the inactive X is not affected by mutations in MECP2. This
suggests that this specific methyl-DNA binding protein
does not have a major role in silencing the inactive X
through histone modification.
Results
Cytological analysis of histone modification
DNMT3B mutant cells (ICF syndrome)
We examined histone modifications known to be associ-
ated with the inactive X chromosome in two ICF cell lines
and normal control cells. Specific histone modifications
including histone H3 and H4 acetylation, and histone H3
methylation at K4 and K9, were examined using antibod-
ies to stain nuclei and metaphases [15-17]. We also exam-
ined histone macroH2A1 staining, which is known to be
concentrated on the inactive X at interphase [25]. One
hundred or more interphase nuclei that had an obvious
sex chromatin body by DAPI staining were scored for his-
tone modification. For acetylated histone (H3 and H4)
and K4-methylated histone H3, the majority (>60%) of
nuclei showed a characteristic hole at the sex chromatin
body in both normal and ICF cells (Fig. 1A). For histone
H3 methylation at K9, the frequency of positive cells (Fig.
1B) was lower (about 50%). We often noted a positive sig-
nal for methylated K4 histone H3 in an otherwise nega-
tive-staining sex chromatin region in both normal and
ICF cells (Fig. 1A). This signal appears to derive from the
DXZ4 locus that was previously reported by Chadwick
and Willard [19] as having active-type histone modifica-
tions. DXZ4 is a megabase-sized region known to be
hypermethylated on the active X and hypomethylated on
the inactive X in normal cells [26]; this locus appears to be
modified normally in ICF cells. Surprisingly, we did not
observe this signal on metaphase spreads, suggesting that
our resolution on these preparations may be much lower
than on interphase chromatin. For metaphase spreads
(acetylated histone H3 and H4 and histone H3BMC Biology 2004, 2:21 http://www.biomedcentral.com/1741-7007/2/21
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The interphase inactive X in normal and mutant cells: histone modification and macroH2A1 association Figure 1
The interphase inactive X in normal and mutant cells: histone modification and macroH2A1 association. Phot-
omicrograph examples of normal, ICF, and Rett fibroblasts that were FITC-labeled using antisera to various modified histones. 
Arrows point to sex chromatin on DAPI-stained cells, and to the corresponding sex chromatin site in the FITC-labeled photo. 
A. Normal, ICF, and Rett fibroblasts FITC-labeled using antisera to acetylated histone H4 (acH4), acetylated histone H3 
(acH3), and dimethylated K4 histone H3 (meK4H3). Note that the sex chromatin body is not stained by these antibodies and 
appears as a hole or a gap that occasionally contains a prominent dot (see insets). This FITC-stained dot appears to correspond 
to the DXZ4 domain, as described in the text. B. Normal and ICF fibroblasts labeled with antibody to dimethylated K9 histone 
H3 (meK9H3) and macrohistone H2A1 (macroH2A).BMC Biology 2004, 2:21 http://www.biomedcentral.com/1741-7007/2/21
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methylated at K4) we analyzed 50 cells per line, and in the
great majority of analyzable metaphases (>80%) a single
lightly-labeled chromosome was detected (Fig. 2). In
some of these cells, the tip of the short arm was labeled, as
would be expected for the pseudoautosomal region (Fig.
2).
The expected patterns of macroH2A1 histone concentra-
tion and histone modification on the inactive X were
found in cells derived from ICF individuals and in control
normal cells (Figs. 1 and 2 and Table 1). At the cytological
level, therefore, no difference could be found between
normal and ICF cells with respect to the histone modifica-
tions on the inactive X.
MECP2 mutant cells (Rett syndrome)
We examined histone modifications and macrohistone
association in clones from two individuals heterozygous
for a mutation in MECP2, an X-linked gene that is subject
to X inactivation [12]. MECP2 mutations lead to Rett syn-
drome, and the protein product codes for a methyl-CpG
binding protein known to recruit a transcriptional silenc-
ing complex that deacetylates histones. In Rett syndrome
and in mice with mutant Mecp2, histones exhibit hyper-
acetylation [10,13], as would be expected if this methyl-
DNA binding protein functions upstream of histone mod-
ification. In one case, we had complementary clones with
either the mutant (1786YY) or wild type MECP2 allele
(1786QQ) on the inactive X, and in the second case, we
had one clone with the wild type MECP2 on the inactive
X (1789V) [27]. For all the histone modifications we
examined (H3 and H4 acetylation and H3 K4 and K9
methylation), the cytological patterns on the active and
inactive X chromosomes in mutant MeCP2-expressing
cells were indistinguishable from those in clones express-
ing the wild type allele or in other control cultures (Fig. 1).
These results suggest that MeCP2 does not function in
determining these histone modification patterns on the
inactive X chromosome.
ChIP analysis
To verify our cytological histone modification results at
the gene level, we searched for promoter polymorphisms
at seven X-linked loci (G6PD, NEMO, MECP2, SYBL1, AR,
FMR1, and PGK1) in ICF cells so that we could employ
allele-specific chromatin immunoprecipitation (ChIP)
analysis. We restricted our search for polymorphisms to
the promoter region, as several reports have indicated that
marked differences in histone modifications between
active and inactive alleles are seldom detected at other
regions [28-30]. We found useful promoter polymor-
phisms at two loci, SYBL1 (synaptobrevin-like gene in the
pseudoautosomal portion of Xq28) and AR (androgen
receptor in Xq12).
Histone modification on the inactive X in metaphases from  normal and ICF fibroblasts (FB) Figure 2
Histone modification on the inactive X in met-
aphases from normal and ICF fibroblasts (FB). Exam-
ples are shown of normal and ICF (PT3 and PT4) metaphase 
cells labeled with antisera to acetylated histone H4 (anti-
acH4) and dimethylated K4 histone H3 (anti-meK4H3). 
Arrows point to X chromosomes stained with DAPI that 
correspond to Xs stained lightly with FITC-antibodies. Note 
the densely-stained acH4 region on the tip of the inactive X 
short arm in PT4. Such staining is also seen in normal cells 
and corresponds to the actively transcribed pseudoauto-
somal region. These observations indicate that on the inac-
tive X, H4 is hypoacetylated and K4 H3 is hypomethylated in 
both normal and ICF cells.BMC Biology 2004, 2:21 http://www.biomedcentral.com/1741-7007/2/21
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Previously, one of us (RSH) has reported on a ChIP study
at the SYBL1 locus in male ICF cells where the inactive Y
allele had reactivated and the histone modification pat-
tern was that of an active gene [31]. Here we report on
ChIP studies at the SYBL1 and AR loci in ICF female cul-
tures using antibodies to histone H3 dimethylated at K4
and to acetylated histone H3. Both loci are subject to X
inactivation, and the inactive X alleles remain inactive in
ICF cells even though the 5' CpG islands are hypomethyl-
ated [23]. In the case of the SYBL1 inactive X allele, the
methylation level is reduced by over 90% with most chro-
mosomes exhibiting no methylation. An XhoI restriction
site polymorphism in the untranslated exon 1 of SYBL1
permitted separation of the active and inactive alleles in
cloned cells. A CAG repeat number polymorphism in the
5' coding region of the AR gene (1.3 kb downstream of the
transcription start site according to reference sequence
NM000044) was informative in one ICF sample (PT 4)
and in several controls, thus permitting separation of the
active and inactive alleles in cloned cells, and in cultures
with highly skewed X inactivation. The antibodies were
highly specific under the amplification conditions cho-
sen, so that a strong signal was seen for the pull-down
experiment with antibody and little or no signal for the
"no antibody" control (Fig. 3A).
The fluorescent amplification products from the AR gene
were then separated on an automated sequencer accord-
ing to CAG repeat number. Two major peaks are detected
in the input control DNA, corresponding to the active (A)
and inactive (I) X alleles, differing in CAG repeat number
(Fig. 3B). An allele was determined to be from the active
X by RT-PCR analysis (data not shown). The lesser
"shadow band" peaks, labeled S, probably derive from
PCR errors. In the methylated K4 H3 and acetylated H3
antibody ChIPs, a single peak predominates in both nor-
mal and ICF cells (Figs. 3B and 3C) that corresponds to
the active X allele.
Our ChIP analysis of the inactive X at the SYBL1 locus in
an ICF female (PT3) also showed normal histone H3
hypoacetylation and K4 H3 hypomethylation in spite of
the very low levels of DNA methylation in this CpG island
region (Fig. 4). These data, therefore, agree with our cyto-
logical observations in that only the active X alleles are
positive for the histone modifications known to be asso-
ciated with active genes, though a minor portion of the
inactive X allele was found to precipitate with the
acetylated H3 antibody in both normal and ICF cells (Fig.
3C and data not shown).
Discussion
The major observation reported here is that ICF cells,
despite being hypomethylated at gene- and L1-associated
CpG islands on the inactive X chromosome, exhibit the
same histone modification patterns as inactive Xs in nor-
mal cells. In addition, we show that cells mutant for
MeCP2, a methyl DNA binding protein, also exhibit nor-
mal histone modification patterns on the inactive X.
These results imply that DNA methylation and/or this
methyl DNA binding protein are not critical for determin-
ing histone modification patterns on the inactive X
chromosomes.
Two major questions can be raised about our results: (1)
is the sensitivity of the cytological histone modification
assay too low to detect active-type histone modifications
on the ICF inactive X? and (2) is the extent of methylation
on the ICF inactive X greater than is suggested by CpG
island and LINE-1 methylation patterns?
The cytological results imply that most of the genes on the
inactive X in ICF cells are subject to inactivation, a conclu-
sion supported by our allele-specific expression analyses
of individual genes, such as AR, in ICF cells ([23] and data
not shown). For genes subject to X inactivation in ICF
cells, we expect histone modifications at the gene level to
be similar to those detected cytologically at the
chromosome level, and this is what we have shown here
Table 1: Inactive X histone modification patterns
Histone Modification Normal PT3 ICF PT4 ICF Rett 1 Rett 2
H3 acetylationa -----
H4 acetylationa -----
H3 methyl K9b +++++
H3 methyl K4a -----
Macro H2A1c +++++
aover 60% of DAPI-stained Barr bodies exhibit lack of antibody staining
bover 50% of DAPI-stained Barr bodies exhibit enhanced antibody staining
cover 80% of DAPI-stained Barr bodies exhibit enhanced antibody stainingBMC Biology 2004, 2:21 http://www.biomedcentral.com/1741-7007/2/21
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for the AR gene. For genes that escape X inactivation in ICF
cells, we expect their histone modification patterns to be
those of expressed genes, and one of us (RSH) has previ-
ously reported this to be the case for the SYBL1 gene ([31]
and data not shown). We did not detect these active pat-
terns cytologically, suggesting that there are no large
blocks of genes escaping inactivation in ICF cells except at
the Xp pseudoautosomal region, which normally contains
escaping genes (Fig. 2).
Methylation levels at inactive X-linked CpG islands in ICF
cells are decreased by an average of 89% from normal as
determined by bisulfite analyses at the G6PD, FMR1, and
SYBL1 loci, and many of the cloned alleles analyzed were
completely unmethylated like active X alleles [23]. It is
possible that DNA methylation at other CpG-rich regions
(e.g., Alu and LINE-1 elements) on the X chromosome
might be differentially methylated and play a role in the X
chromosome histone modification pathway. One of us
(RSH) has recently shown that LINE-1 elements are hyper-
methylated on both active and inactive X chromosomes in
normal cells but, surprisingly, they are hypomethylated
on the inactive X and hypermethylated on the active X in
ICF cells [24]. These results argue against a role for LINE-
1 methylation in histone modification on the inactive X
chromosome. A more complete DNA methylation analy-
sis of the ICF and normal inactive Xs needs to be done,
however, because other widespread sequences may be
hypermethylated on the ICF inactive X that could direct
histone modifications.
Because we know that promoter methylation is important
in gene expression, it seems reasonable that if DNA
methylation were directly involved in the histone modifi-
cation pathway, CpG island methylation would play a
critical role. Further support for this idea comes from the
fact that histone modifications distinguishing active and
inactive X-linked genes are concentrated in promoter
regions [28,32]. In fact, Rougeulle et al. [32] propose that
the promoter-restricted histone modification seen at X-
linked loci may be unique to monoallelically-expressed
genes and provide them with an epigenetic mark.
That DNA methylation is not critical to the developmental
appearance of histone modifications is further supported
by recent murine studies showing that differential histone
modification of the Xs in early development precede dif-
ferential developmental appearance of DNA methylation
[33,34]. The fact that DNA methylation does not appear
to be critical to the development of histone modifications
in X-linked gene expression should not be confused with
a more important role for DNA methylation in maintain-
ing repression of X-linked genes. Some years ago we
showed that the earliest events in reactivating inactive X-
linked genes were hemidemethylation followed by
ChIP analysis of histone modification at the promoter region  of the AR gene Figure 3
ChIP analysis of histone modification at the pro-
moter region of the AR gene. Allele-specific ChIP analysis 
for H3 acetylation and H3 K4 methylation was performed 
using the highly polymorphic CAG repeat region in the 5' 
coding region of the androgen receptor in Xq12. A. "Nor-
mal" isoX fibroblasts with highly skewed inactivation 
(GM00088) and cloned fibroblasts from normal (1871) and 
ICF (PT4) cultures were subjected to ChIP and the immuno-
precipitated material was amplified for AR analysis in two 
stages; nested FAM-labeled primers were used in the second 
stage for size analysis on an automated sequencer. The ethid-
ium bromide-stained agarose gel of the secondary PCR prod-
ucts show strong signals in the input (Inp), anti-H3 dimethyl 
K4 antibody (mK4), and anti-H3 acetyl K9, K14 (acH3), but 
little or no signal in the "no antibody" controls (-). The weak 
bands with slower migration correspond to heteroduplexes 
with the primary amplimer, but these do not interfere with 
the allele-specific analysis of the denatured product. B. and C. 
Allele-specific analyses of the products shown in A, using an 
automated sequencer, revealed that the active X alleles (Xa) 
in normal cells (1871 and GM00088) are hypermethylated at 
H3 K4 (H3meK4) and hyperacetylated at H3 K9, K14 
(AcetylH3), whereas the corresponding inactive X (Xi) alleles 
are hypomethylated and hypoacetylated. ICF cells (PT4) 
showed the same active X versus inactive X modifications as 
normal cells. "Shadow bands" (s) probably correspond to 
PCR errors. Allele assignment was ascertained by a similar 
method using allele-specific RT-PCR with DNased RNA.
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chromatin hypersensitivity, and then transcription factor
binding and transcription [35,36]. More extensive studies
have recently pointed to a similar conclusion [11,37,38].
Thus, DNA methylation appears to play a dominant role
in maintaining repression, even though it is a late event in
establishing silent chromatin.
We can also consider the implication of this work for the
proposed role of methyl-CpG binding proteins in the his-
tone modification pathway. Our ICF cell data and the
results from murine developmental studies, showing that
histone modification of X-linked genes precedes DNA
methylation, argue against such a role for the X chromo-
some. A role for methyl-DNA binding proteins in the his-
tone modification pathway is supported by studies with
Rett syndrome cells where a methyl-DNA binding protein,
MeCP2, is mutated. In both humans and mice with Rett
syndrome mutations, general hyperacetylation of his-
tones was reported, albeit at different sites. In human cell
lines, H4 was hyperacetylated preferentially at K16 [10],
while in mouse mutant tissues hyperacetylation was
reported specifically at H3K9 [10,13]. In our work, how-
ever, we saw no major effect of two different MECP2
mutations on inactive X histone modification. The recent
discovery that LINE-1 elements on the inactive X are
methylated by a methyltransferase distinct from the one
that carries out the same modification on the active X
raises the possibility that the inactive X could have its own
ChIP analysis of histone modification at the SYBL1 promoter region Figure 4
ChIP analysis of histone modification at the SYBL1 promoter region. Allele-specific ChIP analysis for H3 acetylation 
and H3 K4 methylation was performed using an XhoI polymorphism in the 5' UTR of the SYBL1 gene in the Xq28 pseudoauto-
somal region that is also present on the Y chromosome. In normal male cells, the Y-linked locus is inactivated, hypermethyl-
ated, and late-replicating as is the inactive X allele in female cells [23,31,49]. To determine if this region has abnormal histone 
modifications on the X-inactivated but DNA hypomethylated ICF female X, ChIP assays were performed for acetylated histone 
H3 (acH3) and K4-methylated histone H3 (mK4) in normal male lymphoblasts and in PT3 ICF female fibroblasts; the ethidium 
bromide-stained gels of each sample are shown before and after digestion with XhoI. The undigested alleles (XhoI+) are 268 
bp; the digested alleles (XhoI-) result in fragments of 108 and 260 bp. The ChIP assay for acetylated histone H3 (acH3) shows 
that only the XhoI-digested allele (XhoI+) is hyperacetylated in a normal male lymphoblast (NMLB1), and this corresponds to 
the active X allele (Xa) by RT-PCR (data not shown). An hTERT-transformed clone of PT3 ICF fibroblasts was also analyzed by 
ChIP. This clone has normal monoallelic expression of SYBL1 even though the promoter region is extremely hypomethylated 
as determined by bisulfite methylation analysis of DNA. The inactive X allele in the PT3 clone is hypoacetylated at histone H3 
and hypomethylated at H3K4 because only the active X allele (XhoI-) is immunoprecipitated with either the acetylated or K4-
methylated histone H3 antibodies (although a small portion of the inactive X also appears to have been precipitated by the 
acetylated H3 antibody).BMC Biology 2004, 2:21 http://www.biomedcentral.com/1741-7007/2/21
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modification rules [24]. We must consider, therefore, the
possibility that the inactive X chromosome does not uti-
lize methyl-DNA binding proteins in the histone modifi-
cation pathway. Such a possibility would fit with the
failure to detect protein footprints at promoters on the
inactive X chromosome, whereas they are readily detecta-
ble on the active X [36,39-42]. It should be noted that
only a small fraction of possible histone modifications
have been elucidated at this time, and it is possible that
histone modification on the inactive X that depends on
methyl-DNA binding protein(s) will be found in the
future.
Finally, we would like to comment on the implication of
this study regarding the inactive X silencing complex. Sys-
tems controlling gene expression tend to be multilayered
and the X inactivation system is no exception. We know
that silencing on the inactive X involves XIST RNA, DNA
methylation, histone modification patterns, chromatin
sensitivity, and delayed replication. It is our opinion that
these factors tend to act in a more or less independent
manner, as we have suggested several times in the past
[23,43-46]. For example, promoter demethylation of
inactive X-linked genes, as occurs in ICF cases, does not
necessarily lead to reactivation; markedly advanced repli-
cation time must also be present for reactivation to take
place [23]. The present study would appear to add further
support to this idea.
Conclusions
The inactive X chromosome in mammalian cells is charac-
terized by a particular set of histone modifications. It has
been suggested that methyl-DNA binding proteins may be
involved in these modifications through their interactions
with histone deacetylases. We have investigated this idea
by studying histone modification patterns on the inactive
X in ICF and Rett syndrome cells. ICF cells are hypometh-
ylated on the inactive X, in contrast to normal cells, and
the Rett cells we studied were deficient in MeCP2, a spe-
cific X-linked methyl-DNA binding protein. We found
that the histone modification patterns on the inactive X in
these mutant cells were indistinguishable from those in
normal cells. We conclude that DNA methylation and the
associated methyl-DNA binding proteins do not appear to
play a critical role in determining histone modification
patterns on the mammalian inactive X chromosome,
either globally or at the level of the promoter.
Methods
Cells and cell culture
Mutant fibroblast cell cultures included two from female
ICF individuals, whose DNMT3B  mutations have been
previously described [20], and complementary clonal cul-
tures from an individual (Rett 1) heterozygous for a muta-
tion (1155del132) in the MECP2 gene [27]. In one clone
(1786YY), the mutant gene is on the active X, leading to a
culture with nonfunctional MeCP2 protein; the comple-
mentary control clone (1786QQ) has functional MeCP2
because the mutant gene is on the inactive X. In another
clone (1789V), derived from a Rett individual with the
mutation R106W (Rett 2), the active X carried the mutant
allele. Normal fibroblast cultures were obtained from
commercial sources. For chromatin precipitation studies,
the ICF fibroblast clones were immortalized with hTERT,
as previously described [47].
Cells were grown in AmnioMax-C100 (Gibco Invitrogen
Corp.; Carlsbad, CA) and harvested in trypsin:EDTA
(Gibco Invitrogen Corp.) under standard conditions
[46,48].
Cytology
For analysis of interphase stages, cells were plated on alco-
hol-washed 22 mm square cover slips in 35 × 10 mm Petri
dishes. On the following day the medium was removed
and the cells were washed once with PBS followed by fix-
ation in 95% ethanol:5% acetic acid for 1 min at room
temperature. The rest of the procedure followed the
"Immunocytochemistry Protocol" of Upstate (Lake
Placid, NY). DAPI-stained slides mounted in antifade
were examined with a Nikon Microphot FXA microscope
and images were captured with a Nikon Coolpix 995 dig-
ital camera. The inactive X was recognized under DAPI
staining as sex chromatin. Absence of a particular histone
modification on the inactive X was seen as a hole or gap
at the sex chromatin location.
For analysis of metaphase cells, we plated cells in 150 × 25
mm tissue culture dishes and added colcemid (Gibco Inv-
itrogen Corp.) 48 h later (0.1 µg/ml for 2 h). The medium
was removed and the cells were washed once with Hanks'
balanced salt solution, followed by trypsinization (Gibco
Invitrogen Corp.) with slight agitation to collect met-
aphase cells. Serum was added to stop tryptic action and
the cells were recovered by centrifugation, then placed in
hypotonic solution (3 mg/ml KCl and 1 mg/ml sodium
citrate) at 37°C for 15 min. Cells were collected on to
slides using a Cytospin centrifuge and then fixed in 95%
ethanol:5% acetic acid for 1 min. The rest of the procedure
followed the Upstate protocol mentioned above, fol-
lowed by DAPI staining, mounting in antifade, and exam-
ination with a Nikon Microphot FXA microscope.
Antibodies used to detect histone modifications were
obtained from Upstate and included: "Anti-acetyl-His-
tone H4," recognizing acetylated lysines 5, 8, 12, and 16,
"Anti-acetyl-Histone H3 (Lys 9)," "Anti-dimethyl-Histone
H3 (Lys 9)," "Anti-dimethyl-Histone H3 (Lys 4)," and
"Anti-Histone macroH2A1."BMC Biology 2004, 2:21 http://www.biomedcentral.com/1741-7007/2/21
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ChIP studies
Chromatin immunoprecipitation was performed using
the protocol of Upstate with slight modifications. For
each experiment, a near-confluent 75 cm2 tissue culture
flask (about 3 × 106 cells) was washed with PBS and
treated with 4% formaldehyde (pH > 7) for 10 min at
37°C. Protease inhibitor cocktail (Complete) from Roche
Diagnostics (Indianapolis, IN) was used in place of indi-
vidual inhibitors, and Protein A-Separose 4B (Zymed Lab-
oratories Inc.; South San Francisco, CA) was used to
collect immune complexes. After elution of immune com-
plexes, they were heated at 65°C for 4 h to reverse
crosslinks, and the DNA was recovered with a "QIAquick"
PCR purification kit from Qiagen Inc. (Valencia, CA).
Primary amplification of AR DNA was across the poly-
morphic 5' CAG repeat region as previously described
[23], using 27–35 cycles of PCR amplification with 10%
of the immunoprecipitated material or 50 ng of input
DNA in a 50 µl reaction volume. Allele-specific analysis
was performed by amplifying the primary product with a
5'-FAM-labeled nested primer as previously described
[23], using 6–15 cycles of PCR amplification with 2–10 µl
primary product in a 50 µl reaction volume. All amplifica-
tion conditions were chosen so as to produce visible prod-
ucts by ethidium staining only for antibody-precipitated
material, and not for "no antibody" controls. The fluores-
cent products were then run on an ABI PRISM 310 capil-
lary sequencer (Applied Biosystems; Foster City, CA) to
separate alleles differing in CAG repeat number and ana-
lyzed using GeneScan software (Applied Biosystems).
Allele-specific expression analysis by RT-PCR was per-
formed on DNaseI-treated RNA using a similar procedure
[23].
Analysis of the 5' region of the SYBL1 gene was performed
similarly to that of AR, except the allele-specific reaction
entailed XhoI digestion of the primary amplification
product followed by these products being separated by
agarose gel electrophoresis. Conditions for PCR amplifi-
cation and XhoI digestion were as previously described
[31].
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